AQ2013-06 批次 FT4檢驗院際品管結果報告 |
送檢批號:AQ2013-06 調查期間:2013 年 06 月 03 ~
10 日 參加單位數:20
檢驗單位 代碼 |
確診醫院 代碼 |
檢體方 法編碼 |
檢體試 劑編碼 |
Sample
S1 |
Sample
S2 |
||||||
(ng/dL) |
D 1 |
Z 2 |
Da% 3 |
(ng/dL) |
D 1 |
Z 2 |
Da% 3 |
||||
RH01b |
RH01 |
2 |
5 |
1.55 |
-0.1 |
-0.5 |
-18% |
1.17 |
0.0 |
-0.1 |
-4% |
RH07b |
RH07 |
2 |
3 |
1.67 |
0.0 |
0.4 |
13% |
1.20 |
0.0 |
0.2 |
7% |
RH14 |
RH14 |
2 |
3 |
1.96 |
0.3 |
2.6 |
87% |
1.23 |
0.1 |
0.6 |
18% |
CL009 |
CL009 |
2 |
5 |
1.49 |
-0.1 |
-1.0 |
-33% |
1.13 |
-0.1 |
-0.6 |
-18% |
CL010 |
CL010 |
2 |
6 |
1.80 |
0.2 |
1.4 |
46% |
0.90 |
-0.3 |
-3.1 |
-99% |
CL012 |
CL012 |
2 |
3 |
1.57 |
-0.1 |
-0.4 |
-13% |
0.99 |
-0.2 |
-2.1 |
-67% |
CL013 |
CL013 |
2 |
5 |
1.62 |
0.0 |
0.0 |
0% |
1.15 |
0.0 |
-0.3 |
-11% |
CL015 |
CL015 |
2 |
4 |
1.93 |
0.3 |
2.4 |
80% |
1.12 |
-0.1 |
-0.7 |
-21% |
Median of RIA Group |
1.65 |
1.14 |
|||||||||
Range of RIA Group |
1.49 – 1.96 |
0.90 – 1.23 |
|||||||||
Robust average4 of RIA Group |
1.70 ( n = 8 ) |
1.12 ( n = 8 ) |
|||||||||
Robust SD4 of RIA Group |
0.20 |
0.11 |
|||||||||
CV of RIA Group |
11.8% |
9.8% |
|||||||||
Median of European RIA labs |
1.63 ( n = 107 ) |
1.17 ( n = 104 ) |
|||||||||
Range of European labs (16% – 84%) |
1.47 – 1.87 |
1.06 – 1.42 |
RH01a |
RH01 |
4 |
9 |
1.88 |
0.3 |
2.0 |
67% |
1.39 |
0.2 |
2.3 |
74% |
RH02c |
RH02 |
4 |
1 |
1.41 |
-0.2 |
-1.6 |
-54% |
0.93 |
-0.3 |
-2.8 |
-88% |
RH06 |
RH06 |
4 |
9 |
1.70 |
0.1 |
0.6 |
21% |
1.22 |
0.0 |
0.4 |
14% |
RH07a |
RH07 |
4 |
2 |
1.27 |
-0.4 |
-2.7 |
-90% |
1.10 |
-0.1 |
-0.9 |
-28% |
RH12 |
RH12 |
4 |
2 |
1.37 |
-0.3 |
-1.9 |
-64% |
1.02 |
-0.2 |
-1.8 |
-56% |
RH19 |
RH19 |
4 |
2 |
1.38 |
-0.2 |
-1.8 |
-62% |
1.08 |
-0.1 |
-1.1 |
-35% |
RH20 |
RH20 |
4 |
7 |
1.55 |
-0.1 |
-0.5 |
-18% |
1.11 |
-0.1 |
-0.8 |
-25% |
CL005 |
CL005 |
4 |
9 |
1.67 |
0.0 |
0.4 |
13% |
1.23 |
0.1 |
0.6 |
18% |
CL006a |
CL006 |
4 |
7 |
1.57 |
-0.1 |
-0.4 |
-13% |
1.35 |
0.2 |
1.9 |
60% |
CL008 |
CL008 |
4 |
1 |
1.39 |
-0.2 |
-1.8 |
-59% |
0.90 |
-0.3 |
-3.1 |
-99% |
CL011 |
CL011 |
4 |
13 |
1.65 |
0.0 |
0.2 |
8% |
1.17 |
0.0 |
-0.1 |
-4% |
CL014b |
CL014 |
4 |
1 |
1.42 |
-0.2 |
-1.5 |
-51% |
0.93 |
-0.3 |
-2.8 |
-88% |
Median of CLIA Group |
1.49 |
1.11 |
|||||||||
Range of CLIA Group |
1.27 – 1.88 |
0.90 – 1.39 |
|||||||||
Robust average4 of CLIA Group |
1.51 ( n = 12 ) |
1.12 ( n = 12 ) |
|||||||||
Robust SD4 of CLIA Group |
0.19 |
0.18 |
|||||||||
CV of CLIA Group |
12.6% |
16.1% |
|||||||||
Median of European labs |
1.63 ( n = 986 ) |
1.19 ( n = 947 ) |
|||||||||
Range of European CLIA labs (16% – 84%) |
1.38 – 1.79 |
1.00 – 1.28 |
Median of All Labs |
1.57 |
1.13 |
Range of All Labs |
1.27 – 1.96 |
0.90 – 1.39 |
Robust average4 of All Labs |
1.59 ( n = 20 ) |
1.11 ( n = 20 ) |
Robust SD4 of All Labs |
0.21 |
0.15 |
CV of All Labs |
13.2% |
13.5% |
Median of All European Labs |
1.62 |
1.18 |
Range of All European Labs (16% – 84%) |
1.38 – 1.80 |
0.99 – 1.29 |
Mean of All European Labs |
1.60 ( n = 1177 ) |
1.16 ( n = 1140 ) |
SD of All European Labs |
0.20 |
0.15 |
CV of All European Labs |
12.7% |
13.0% |
1. D = X - Xa 2. Zscore
= D / Target SD 3. Da% (Your result from
target as percentages of allowed deviation) = D/(Xa
x MAD) x 100% 4. Robust results were
calculated by Algorithm A according to ISO 13528:2005 and IUPAC/CITAC Guide: Selection
and use of proficiency testing scheme for a limited number of participants.
Pure Appl Chem 2010;82:1099 – 135. 5. The Target value (Xa)
is the median of the results of this control material used
in European surveys. 6. Maximum allowable deviation
(MAD) 24%, Target SD = 8% x Xa |
|
Sample
S1 |
Sample
S2 |
Target value (Xa)5 (1
pmol/L = 0.0777 ng/dL) |
1.62 ng/dL = 20.9
pmol/L ( n = 1177 ) |
1.18 ng/dL = 15.2 pmol/L ( n = 1140 ) |
Target SD6 |
0.13 |
0.09 |
Method Name |
Method Code |
Laboratory |
Radioimmunoassay ( Competitive - type ) |
2 |
RH01b, RH07b, RH14, CL009, CL010, CL012, CL013,
CL015, |
Chemiluminescent Immunoassay ( Competitive - type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005,
CL006a, CL008, CL011, CL014b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
CL008, CL014b, RH02c, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, |
Cisbio RIA-gnost |
3 |
CL012, RH07b, RH14, |
Diasorin |
4 |
CL015, |
Immunotech |
5 |
CL009, CL013, RH01b, |
MP |
6 |
CL010, |
Siemens ADVIA Centaur |
7 |
CL006a, RH20, |
Siemens Immulite 2000 |
9 |
CL005, RH01a, RH06, ` |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北信維郵局 624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 05 Jul, 2013